Tower Research Capital LLC (Trc) Next Cure, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.17 - $2.49 $1,224 - $2,607	-1,047 Reduced 46.04%	1,227 $1,000
Q1 2024 May 15, 2024	SELL	$1.13 - $2.23 $6,573 - $12,971	-5,817 Reduced 71.89%	2,274 $5,000
Q4 2023 Feb 13, 2024	BUY	$1.03 - $1.45 $1,080 - $1,521	1,049 Added 14.9%	8,091 $9,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $1.84 $4,366 - $6,228	3,385 Added 92.56%	7,042 $9,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $1.86 $15,351 - $19,423	-10,443 Reduced 74.06%	3,657 $6,000
Q1 2023 May 09, 2023	SELL	$1.46 - $1.83 $10,262 - $12,863	-7,029 Reduced 33.27%	14,100 $21,000
Q4 2022 Feb 10, 2023	BUY	$1.2 - $3.07 $5,704 - $14,594	4,754 Added 29.03%	21,129 $30,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $5.19 $22,320 - $42,589	8,206 Added 100.45%	16,375 $45,000
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.27 $34,800 - $54,259	-10,296 Reduced 55.76%	8,169 $38,000
Q1 2022 May 12, 2022	BUY	$4.76 - $6.24 $71,709 - $94,005	15,065 Added 443.09%	18,465 $90,000
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $6,412 - $10,237	-1,125 Reduced 24.86%	3,400 $20,000
Q3 2021 Nov 15, 2021	BUY	$6.74 - $8.02 $13,143 - $15,639	1,950 Added 75.73%	4,525 $31,000
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $3,693 - $4,996	486 Added 23.26%	2,575 $21,000
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $37,690 - $53,326	-3,842 Reduced 64.78%	2,089 $21,000
Q4 2020 Feb 16, 2021	SELL	$9.47 - $12.43 $104,539 - $137,214	-11,039 Reduced 65.05%	5,931 $65,000
Q3 2020 Nov 16, 2020	BUY	$8.15 - $21.17 $119,218 - $309,674	14,628 Added 624.59%	16,970 $149,000
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $42,146 - $79,957	1,989 Added 563.46%	2,342 $50,000
Q1 2020 May 15, 2020	BUY	$32.32 - $58.37 $8,209 - $14,825	254 Added 256.57%	353 $13,000
Q4 2019 Feb 07, 2020	SELL	$25.0 - $92.22 $7,050 - $26,006	-282 Reduced 74.02%	99 $6,000
Q3 2019 Nov 05, 2019	SELL	$15.73 - $41.6 $94,301 - $249,392	-5,995 Reduced 94.02%	381 $12,000
Q2 2019 Aug 13, 2019	BUY	$14.16 - $20.64 $90,284 - $131,600	6,376 New	6,376 $96,000

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

Sofinnova Investments, Inc. Menlo Park, CA

2.67M
Shares

$2.11 Million
0.35% of portfolio
Logos Global Management LP San Francisco, CA

2.5M
Shares

$1.98 Million
0.45% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.3M
Shares

$1.82 Million
0.54% of portfolio
Orbimed Advisors LLC San Diego, CA

1.14M
Shares

$901,548
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

987K
Shares

$779,985
0.0% of portfolio

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account